Impact of Socioeconomic Status on Outcomes of Patients with Kawasaki Disease

Audrey Dionne(Boston Children's Hospital), Jane W. Newburger(Oregon Health & Science University), Mary Beth F. Son(Boston Children's Hospital), Sarah D. de Ferranti, Kevin G. Friedman(Boston Children's Hospital), Kimberlee Gauvreau(Boston Children's Hospital), Patrick Gould(Harvard University), David R. Fulton(Tufts Medical Center), Annette Baker(Boston Children's Hospital), Emily M. Bucholz(University of Colorado Denver)
The Journal of Pediatrics
June 20, 2019
10.1016/j.jpeds.2019.05.024
Cited by 16

Related Papers

Heart Disease and Stroke Statistics—2018 Update: A Report From the American Heart Association
|Circulation|2018|7.2k
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
|Circulation|2019|6.2k
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
|Circulation|2017|3.7k
Prevention of Infective Endocarditis
|Circulation|2007|2.8k
Multisystem Inflammatory Syndrome in U.S. Children and Adolescents
|New England Journal of Medicine|2020|2.7k